2022-07-28| Special

BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka

by GeneOnline
Share To

The opening session of BIO-Asia Taiwan 2022 featured a presentation by Professor Shinya Yamanaka from Japan. Prof. Yamanaka, who was awarded the Nobel Prize in Physiology and Medicine in 2012 for his iPSC research, discussed the future vision of popularizing iPSC technology with the title “Top iPS Cell Technologies at Affordable Prices”.

CiRA’s Three Major Strategies for Accelerated Production of iPSC

The CiRA Foundation (Center for iPS Cell Research Application, Kyoto University), a leading regenerative medicine research institute in Japan, was established through the efforts of Prof. Yamanaka to shorten the gap between research and industry in iPSC technology. CiRA has three main strategies to facilitate the advancement of therapeutic applications of iPSC.

It's free! Log in now to read

GHG Emissions as a ESG Metric
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
Scroll to Top